Dynorphin ADynorphin A - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-P1333-01.804-HY-P1333-01804-HY-P1333-01Business & Industrial > Science & LaboratoryDynorphin A
Gentaur
EUR12027-02-21

Dynorphin A

CAT:
804-HY-P1333-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Dynorphin A - image 1

Dynorphin A

  • Description:

    Dynorphin A is an endogenous opioid peptide involved in inhibitory neurotransmission in the central nervous system (CNS) . Dynorphin A is a highy potent kappa opioid receptor (KOR) agonist, and is also an agonist for other opioid receptors, such as mu (MOR) and delta (DOR) . Dynorphin A can induce neuronal death, and can be used in the research of neurological disease[1][2].
  • UNSPSC:

    12352209
  • Target:

    Apoptosis; Caspase; Endogenous Metabolite; Opioid Receptor
  • Type:

    Peptides
  • Related Pathways:

    Apoptosis; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/dynorphin-a.html
  • Purity:

    96.21
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
  • Smiles:

    O=C([C@H]1N(CCC1)C([C@H](CCCNC(N)=N)NC([C@H]([C@@H](C)CC)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@@H](NC(CNC(CNC([C@@H](N)CC2=CC=C(C=C2)O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)=O)=O)N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@H](C(O)=O)CCC(N)=O)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)=O
  • Molecular Formula:

    C99H155N31O23
  • Molecular Weight:

    2147.48
  • References & Citations:

    [1]Zhang, et al.Dynorphin A as a Potential Endogenous Ligand for Four Members of the Opioid Receptor Gene Family. J Pharmacol Exp Ther. 1998 Jul;286 (1) :136-41.|[2]Aruna Sharma, et al. Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair. Int Rev Neurobiol. 2012;102:23-45. |[3]I. N. SINGH, et al. Dynorphin A (1–17) induces apoptosis in striatal neurons in vitro through AMPA/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience. 2003;122 (4) :1013-23. |[4]K F Hauser, et al. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons. Exp Neurol. 1999 Dec;160 (2) :361-75. |[5]B J Van de Heijning, et al. Dynorphin-A and vasopressin release in the rat: a structure-activity study. Neuropeptides. 1994 Jun;26 (6) :371-8. |[6]Takayoshi Mamiya, et al. Dynorphin a (1-13) alleviated stress-induced behavioral impairments in mice. Biol Pharm Bull. 2014;37 (8) :1269-73.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
  • Scientific Category:

    Peptides
  • Clinical Information:

    Phase 2
  • Isoform:

    Caspase 3; Human Endogenous Metabolite; κ Opioid Receptor/KOR
  • CAS Number:

    [80448-90-4]